Skip to content

Child Health Intervention for Development Outcomes (CHIDO)

A trial to determine the effects of a comprehensive community based, multi-component intervention on early childhood development, household economic resilience and adherence and retention in paediatric HIV treatment and care programmes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201701001387209
Enrollment
480
Registered
2015-12-11
Start date
2016-01-13
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS

Interventions

CHIDO intervention
Standard of care

Sponsors

World Education International
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Children who are HIV exposed or confirmed HIV infected aged 0-2 years Living in the catchment areas of trial health care facilities Singleton births Planning to live full time in the community for the following 24 months Able to attend bi-weekly meetings in the community Prepared to provide their residential address and other locator information

Exclusion criteria

Exclusion criteria: Children with chronic illness or disability Planning to travel away from the area in the next 24 months.

Design outcomes

Primary

MeasureTime frame
% of HIV exposed or infected children with full retention in care (>80%) at 12 months will be determined from the child health card cross referenced with the clinic registers and the case manager records.

Secondary

MeasureTime frame
The Early Childhood development sub-scales will be measured using the Mullen Scales of Early Learning;Child height and weight will be measured using standard procedures;Parenting stress will be measured using the 36 item Parenting Stress Index-Short Form (PSI-SF).;% of HIV infected mothers retained in care will be assessed using clinic records and patient had held report card. ;% of HIV infected mothers with a suppressed HIV viral load at 12 months will be assessed on dried blood spot samples using NucliSENS EasyQ HIV-1 assay (BioMe´rieux, Inc., Madrid, Spain);% of HIV exposed or infected children retained in care at 12 months will be determined from the child health card cross referenced with the clinic registers and the case manager records;% of HIV exposed or infected children reporting > 95% adherence to cotrimoxazole +/- ART as appropriate in the previous 24 hours and previous 7 days.;Maternal mental health measured using SSQ8 and EPND scale;Household Food Security measured using modified HFIAS

Countries

Zimbabwe

Contacts

Public ContactRudo Chingono

Trial coordinator

rudo@ceshhar.co.zw+2634308042

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026